Industry Focus Transcripts

Arena Pharmaceuticals has turned its bad luck around, and could be on the path to something huge.

What some of the world's brightest thinkers had to say about artificial intelligence, Chinese e-commerce, voice tech, and more at this year's SXSW conference.

Rumors are swirling that Sirius XM is interested in acquiring the streaming music company. It doesn't make sense at first glance, but Pandora might get by with a little help from Sirius' friends.

We look at recent announcements that could change how you enjoy your favorite movies and shows.

Operating a successful cruise requires significant planning and resources, but these three companies have managed to take over 80% of the $30 billion market.

The Oracle of Omaha’s latest stock pick is unexpected.

The 21st Century Cures Act ignites innovation with perks to biopharma and medical device makers. Also, Kite Pharma and Novartis prep plans to pitch their CAR-T cancer therapies to the FDA.

China is welcoming foreign investors to its markets, but should investors accept the invitation?

With Donald Trump’s upcoming presidency and OPEC’s impending production cut, the energy sector is poised for some big changes.

Tesla has put another quarter on the books, and what a remarkably Tesla-like quarter it was -- for better and for worse.

A long overdue update on the autonomous driving space -- Alphabet's decision to turn it's self-driving car project into an Alphabet subsidiary, what's going on over at Apple, and why Uber is causing problems in San Francisco.

The energy sector is getting strong representation in the Trump administration, and here’s what investors need to know.

Shares in Juno Therapeutics and Amicus Therapeutics tumble on disappointing news, and one important drug at Pfizer takes a big step forward.

While it’s tempting to think that the American economy is still struggling to recover from the financial crisis, the data says otherwise.

The consumer retail giant is dipping its toe into natural pet food with an $8 billion buyout.

Why the short-term focus of private equity often presents long-term challenges for the companies they acquire.

Spotify is live on the public markets. Here's how it’s done so far, and what that means for the company.

It’s a low interest-rate world, but it probably won’t be for long, which means it’s high time for vertical integration.

Takeda may make an offer to buy Shire, but it might prove costly. Also, the FDA slaps Alkermes with a dreaded Refusal to File letter.

The solar industry has seen some big changes in the last few months. Here are a few companies and trends for investors to watch.